Replies to post #383974 on Elite Pharmaceuticals Inc (ELTP)

[Pharma Sleuth]

Company is tracking to :

40m in revenues
40m cap
low P/E while adding millions to R&D
Adding employees and shifts
Selling Adderall with their own sales and marketing team along with a bunch of other drugs
Numerous drugs in trial, development, approval stages
Acquiring another building just due to the expected volume
No Dilution
Plenty of cash
massive tax write-off that plus assets is currently about 1.5x the current market cap by itself

This is a growing, successful American company. It is a unicorn.

you are in a foreign country, hired to post on a message board